Remove 2020 Remove Individual Remove Medical Remove Utilities
article thumbnail

Differences in primary care utilization by primary care availability in the first year of Virginia Medicaid Expansion [Health care disparities]

Annals of Family Medicine

Importantly, Virginia's Medicaid expansion reduced cost-related barriers to accessing care for over 700,000 individuals. Setting or Dataset: 2019-2020 Virginia Department of Medical Assistance Services database (demographic, enrollment, and claims data). Of these, 117,481 (57.2%) individuals had at least one primary care visit.

article thumbnail

Aftershock in Academia: Assessing COVID-19s Impact on Schizophrenia Patients in Academic Medical Centers [Behavioral, psychosocial, and mental illness]

Annals of Family Medicine

Context: The impact of the COVID-19 pandemic on individuals with schizophrenia who are admitted to academic medical centers (AMCs) has not been previously reported. Study Design: This retrospective case series analysis utilizes Vizient’s clinical database data. from Oct 2019 to Dec 2023. Setting: AMCs within the US.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 148: Antiracism in Medicine Series Episode 4 – Dismantling Race-Based Medicine Part 2: Clinical Perspectives

The Clinical Problem Solvers

Our guests explain how we can incorporate race-conscious medicine in clinical settings, medical education, and biomedical/epidemiological research to responsibly recognize and address the harms of racial inequality. These factors include a high-protein diet, muscle mass, creatinine generation, and certain medications.

Clinic 52
article thumbnail

Could the Road to an AKS Violation Be Paved with Good Intentions? Pfizer Asks SCOTUS

FDA Law

In September 2020, the OIG issued an unfavorable advisory opinion to Pfizer, concluding that the proposal was “highly suspect” under the AKS because one purpose of the program, and perhaps the primary purpose, would be to induce Medicare beneficiaries to purchase Pfizer’s federally reimbursable medication. Pfizer’s Petition to SCOTUS.

article thumbnail

3 in 1 Guidance Issued by FDA Covering Formal Dispute Resolution, Administrative Hearings and Consolidated Proceedings for OTC Monograph Drugs

FDA Law

The CARES Act also provides for an administrative hearing process that may be utilized under certain conditions following the formal dispute resolution process. The draft Monograph FDR Guidance clarifies that FDR is appropriate only when there is a scientific and/or medical dispute related to a final order.

article thumbnail

Episode 236: ARM Episode 16 – Live from SGIM: Best of Antiracism Research at the Society of General Internal Medicine’s 2022 Annual Meeting

The Clinical Problem Solvers

Valtis is a 4th year Med-Peds Resident at Brigham & Women’s Hospital and Boston Children’s Hospital, and his research focuses on race and the utilization of security responses in the inpatient hospital setting. Simulation-based training interventions are currently being studied to help combat these inequities.

article thumbnail

Episode 275: Anti-Racism in Medicine Series – Episode 19 – Reframing the Opioid Epidemic: Anti-Racist Praxis, Racial Health Inequities, and Harm Reduction

The Clinical Problem Solvers

Pearls: In 2020, American Indian and Alaska Native (Indigenous) communities experienced the highest drug overdose mortality rate of any racial or ethnic group, also surpassing rates among the non-Hispanic white population. The foundational literature in this area has furthered stigma and bias, especially towards Black birthing persons.